Fleur Cohen‐Aubart

High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses

Julien Haroche, Frédéric Charlotte, Laurent Arnaud et al. · Blood · 2012 · 682 citations

Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Blood · 2012 · 529 citations

Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms

Eli L. Diamond, Benjamin H. Durham, Julien Haroche et al. · Cancer Discovery · 2015 · 518 citations · Full text

<i>BRAF</i> Mutation Correlates With High-Risk Langerhans Cell Histiocytosis and Increased Resistance to First-Line Therapy

Sébastien Heritier, Jean‐François Emile, Mohamed‐Aziz Barkaoui et al. · Journal of Clinical Oncology · 2016 · 327 citations · Full text

Reproducible and Sustained Efficacy of Targeted Therapy With Vemurafenib in Patients With <i>BRAF^V600E</i>-Mutated Erdheim-Chester Disease

Julien Haroche, Fleur Cohen‐Aubart, Jean‐François Emile et al. · Journal of Clinical Oncology · 2014 · 282 citations